Cargando…
The microtubule signature in cardiac disease: etiology, disease stage, and age dependency
Employing animal models to study heart failure (HF) has become indispensable to discover and test novel therapies, but their translatability remains challenging. Although cytoskeletal alterations are linked to HF, the tubulin signature of common experimental models has been incompletely defined. Her...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533615/ https://www.ncbi.nlm.nih.gov/pubmed/37644284 http://dx.doi.org/10.1007/s00360-023-01509-1 |
_version_ | 1785112222460018688 |
---|---|
author | Algül, Sıla Dorsch, Larissa M. Sorop, Oana Vink, Aryan Michels, Michelle dos Remedios, Cristobal G. Dalinghaus, Michiel Merkus, Daphne Duncker, Dirk J. Kuster, Diederik W. D. van der Velden, Jolanda |
author_facet | Algül, Sıla Dorsch, Larissa M. Sorop, Oana Vink, Aryan Michels, Michelle dos Remedios, Cristobal G. Dalinghaus, Michiel Merkus, Daphne Duncker, Dirk J. Kuster, Diederik W. D. van der Velden, Jolanda |
author_sort | Algül, Sıla |
collection | PubMed |
description | Employing animal models to study heart failure (HF) has become indispensable to discover and test novel therapies, but their translatability remains challenging. Although cytoskeletal alterations are linked to HF, the tubulin signature of common experimental models has been incompletely defined. Here, we assessed the tubulin signature in a large set of human cardiac samples and myocardium of animal models with cardiac remodeling caused by pressure overload, myocardial infarction or a gene defect. We studied levels of total, acetylated, and detyrosinated α-tubulin and desmin in cardiac tissue from hypertrophic (HCM) and dilated cardiomyopathy (DCM) patients with an idiopathic (n = 7), ischemic (n = 7) or genetic origin (n = 59), and in a pressure-overload concentric hypertrophic pig model (n = 32), pigs with a myocardial infarction (n = 28), mature pigs (n = 6), and mice (n = 15) carrying the HCM-associated MYBPC3(2373insG) mutation. In the human samples, detyrosinated α-tubulin was increased 4-fold in end-stage HCM and 14-fold in pediatric DCM patients. Acetylated α-tubulin was increased twofold in ischemic patients. Across different animal models, the tubulin signature remained mostly unaltered. Only mature pigs were characterized by a 0.5-fold decrease in levels of total, acetylated, and detyrosinated α-tubulin. Moreover, we showed increased desmin levels in biopsies from NYHA class II HCM patients (2.5-fold) and the pressure-overload pig model (0.2–0.3-fold). Together, our data suggest that desmin levels increase early on in concentric hypertrophy and that animal models only partially recapitulate the proliferated and modified tubulin signature observed clinically. Our data warrant careful consideration when studying maladaptive responses to changes in the tubulin content in animal models. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00360-023-01509-1. |
format | Online Article Text |
id | pubmed-10533615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105336152023-09-29 The microtubule signature in cardiac disease: etiology, disease stage, and age dependency Algül, Sıla Dorsch, Larissa M. Sorop, Oana Vink, Aryan Michels, Michelle dos Remedios, Cristobal G. Dalinghaus, Michiel Merkus, Daphne Duncker, Dirk J. Kuster, Diederik W. D. van der Velden, Jolanda J Comp Physiol B Original Paper Employing animal models to study heart failure (HF) has become indispensable to discover and test novel therapies, but their translatability remains challenging. Although cytoskeletal alterations are linked to HF, the tubulin signature of common experimental models has been incompletely defined. Here, we assessed the tubulin signature in a large set of human cardiac samples and myocardium of animal models with cardiac remodeling caused by pressure overload, myocardial infarction or a gene defect. We studied levels of total, acetylated, and detyrosinated α-tubulin and desmin in cardiac tissue from hypertrophic (HCM) and dilated cardiomyopathy (DCM) patients with an idiopathic (n = 7), ischemic (n = 7) or genetic origin (n = 59), and in a pressure-overload concentric hypertrophic pig model (n = 32), pigs with a myocardial infarction (n = 28), mature pigs (n = 6), and mice (n = 15) carrying the HCM-associated MYBPC3(2373insG) mutation. In the human samples, detyrosinated α-tubulin was increased 4-fold in end-stage HCM and 14-fold in pediatric DCM patients. Acetylated α-tubulin was increased twofold in ischemic patients. Across different animal models, the tubulin signature remained mostly unaltered. Only mature pigs were characterized by a 0.5-fold decrease in levels of total, acetylated, and detyrosinated α-tubulin. Moreover, we showed increased desmin levels in biopsies from NYHA class II HCM patients (2.5-fold) and the pressure-overload pig model (0.2–0.3-fold). Together, our data suggest that desmin levels increase early on in concentric hypertrophy and that animal models only partially recapitulate the proliferated and modified tubulin signature observed clinically. Our data warrant careful consideration when studying maladaptive responses to changes in the tubulin content in animal models. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00360-023-01509-1. Springer Berlin Heidelberg 2023-08-29 2023 /pmc/articles/PMC10533615/ /pubmed/37644284 http://dx.doi.org/10.1007/s00360-023-01509-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Algül, Sıla Dorsch, Larissa M. Sorop, Oana Vink, Aryan Michels, Michelle dos Remedios, Cristobal G. Dalinghaus, Michiel Merkus, Daphne Duncker, Dirk J. Kuster, Diederik W. D. van der Velden, Jolanda The microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
title | The microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
title_full | The microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
title_fullStr | The microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
title_full_unstemmed | The microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
title_short | The microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
title_sort | microtubule signature in cardiac disease: etiology, disease stage, and age dependency |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533615/ https://www.ncbi.nlm.nih.gov/pubmed/37644284 http://dx.doi.org/10.1007/s00360-023-01509-1 |
work_keys_str_mv | AT algulsıla themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dorschlarissam themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT soropoana themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT vinkaryan themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT michelsmichelle themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dosremedioscristobalg themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dalinghausmichiel themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT merkusdaphne themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dunckerdirkj themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT kusterdiederikwd themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT vanderveldenjolanda themicrotubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT algulsıla microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dorschlarissam microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT soropoana microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT vinkaryan microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT michelsmichelle microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dosremedioscristobalg microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dalinghausmichiel microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT merkusdaphne microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT dunckerdirkj microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT kusterdiederikwd microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency AT vanderveldenjolanda microtubulesignatureincardiacdiseaseetiologydiseasestageandagedependency |